Results 31 to 40 of about 2,955 (162)
Genitourinary Syndrome of Menopause Assessment Tools [PDF]
Journal of Mid-life Health, 2021 New therapeutic options are being considered to treat genitourinary syndrome of menopause (GSM), such as vaginal laser, ospemifene, or prasterone, but there is no explicit agreement in the scientific community for its use. Some concerns have arisen on how to evaluate the improvement of GSM symptoms.
Mension Coll, Eduard +8 more
openaire +3 more sources
The Recent Review of the Genitourinary Syndrome of Menopause [PDF]
Journal of Menopausal Medicine, 2015 The genitourinary syndrome of menopause (GSM) is a new term that describes various menopausal symptoms and signs including not only genital symptoms (dryness, burning, and irritation), and sexual symptoms (lack of lubrication, discomfort or pain, and impaired function, but also urinary symptoms (urgency, dysuria, and recurrent urinary tract infections).
Kim, Hyun-Kyung +4 more
openaire +2 more sources
BMC Cancer, 2023 Background Vaginal CO2 laser therapy is a new treatment option for genitourinary syndrome of menopause. Its potential is particularly interesting in breast cancer survivors, where existing treatment options often are insufficient as hormonal treatment is
Sine Jacobsen +4 more
doaj +1 more source
Revitalizing research in genitourinary syndrome of menopause [PDF]
American Journal of Obstetrics and Gynecology, 2019 Genitourinary syndrome of menopause is defined as the collection of signs and symptoms of the genitourinary tract from menopause, previously known as vulvovaginal atrophy. The Food and Drug Administration has approved select hormonal and nonhormonal treatment for vaginal atrophy, including systemic estrogen, vaginal estrogen, estrogen receptor ...
Olivia H. Chang, Marie Fidela R. Paraiso
openaire +4 more sources
Genitourinary syndrome of menopause: optimization of therapyfor vaginal symptoms [PDF]
Гинекология, 2018 The aim of the study was to investigate the dynamics of atrophic changes оn the use of low-dose regimens of local therapy with a druge containing only estriol and a druge containing estriol, progesterone and a culture of lactobacilli in patients with ...
E G Eprikyan +3 more
doaj +1 more source
Efficacy of Fractional Laser on Steroid Receptors in GSM Patients
Bioengineering, 2023 Background: To compare the efficacy of CO2 fractional laser with that of topical estriol for treating genitourinary syndrome of menopause and to investigate the relationship between epithelial thickness and vaginal atrophy.
Stella Catunda Pinho +9 more
doaj +1 more source
Therapies for the management of genitourinary syndrome of menopause [PDF]
Post Reproductive Health, 2019 Introduction The genitourinary syndrome of menopause is a new term that describes various menopausal symptoms and signs including not only genital symptoms (dryness, burning, and irritation) and sexual symptoms (lack of lubrication, discomfort or pain, and impaired function), but also urinary symptoms (urgency ...
Santiago Palacios +4 more
openaire +2 more sources
The controversies regarding the role of estrogens in urogynecology.
Folia Histochemica et Cytobiologica, 2008 Estrogens are crucial for the proper functioning of genitourinary tract. Hypoestrogenism related to menopause could be linked to numerous disturbances of lower urinary tract.
Tomasz Rechberger, Pawel Skorupski
doaj +3 more sources
ESTRIOL IN THERAPY OF VARIOUS GYNECOLOGICAL DISEASES
Медицинский совет, 2017 Estriol is an effective and safe drug to treat climacteric syndrome, genitourinary syndrome, in a complex therapy of genital organs prolapsed, atrophic processes at the menopause stage, hypoestrogenia, at cervical factor of infertility.
V. N. Prilepskaya, E. G. Nazarenko
doaj +1 more source
Pakistan Armed Forces Medical JournalObjective: To assess the impact of genitourinary syndrome of menopause on well-being, functioning and quality of life (QoL) in postmenopausal women. Study Design: Cross-sectional survey.
Asma Batool +3 more
doaj +1 more source